Prestige Brand Holdings Inc - Asset Resilience Ratio

Latest as of December 2025: 1.78%

Prestige Brand Holdings Inc (PBH) has an Asset Resilience Ratio of 1.78% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Prestige Brand Holdings Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$62.37 Million
Cash + Short-term Investments

Total Assets

$3.49 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Prestige Brand Holdings Inc's Asset Resilience Ratio has changed over time. See PBH equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Prestige Brand Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Prestige Brand Holdings Inc stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $62.37 Million 1.78%
Short-term Investments $0.00 0%
Total Liquid Assets $62.37 Million 1.78%

Asset Resilience Insights

  • Limited Liquidity: Prestige Brand Holdings Inc maintains only 1.78% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Prestige Brand Holdings Inc Industry Peers by Asset Resilience Ratio

Compare Prestige Brand Holdings Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Aurobindo Pharma Limited
NSE:AUROPHARMA
Drug Manufacturers - Specialty & Generic 1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
Drug Manufacturers - Specialty & Generic -0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
Drug Manufacturers - Specialty & Generic 0.20%
Xeris Pharmaceuticals Inc
NASDAQ:XERS
Drug Manufacturers - Specialty & Generic 0.00%
Procter & Gamble Health Limited
NSE:PGHL
Drug Manufacturers - Specialty & Generic 33.01%

Annual Asset Resilience Ratio for Prestige Brand Holdings Inc (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Prestige Brand Holdings Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 2.88% $97.88 Million $3.40 Billion +1.48pp
2024-03-31 1.40% $46.47 Million $3.32 Billion -0.34pp
2023-03-31 1.74% $58.49 Million $3.35 Billion +1.00pp
2022-03-31 0.74% $27.18 Million $3.67 Billion -0.20pp
2021-03-31 0.94% $32.30 Million $3.43 Billion -1.75pp
2020-03-31 2.70% $94.76 Million $3.51 Billion +1.90pp
2019-03-31 0.80% $27.53 Million $3.44 Billion -0.07pp
2018-03-31 0.87% $32.55 Million $3.76 Billion -0.20pp
2017-03-31 1.07% $41.85 Million $3.91 Billion --
2016-03-31 0.00% $0.00 $2.95 Billion --
2015-03-31 0.00% $0.00 $2.67 Billion --
2014-03-31 0.00% $0.00 $1.80 Billion --
2013-03-31 0.00% $0.00 $1.74 Billion --
2012-03-31 0.00% $0.00 $1.76 Billion --
pp = percentage points

About Prestige Brand Holdings Inc

NYSE:PBH USA Drug Manufacturers - Specialty & Generic
Market Cap
$2.25 Billion
Market Cap Rank
#5940 Global
#1861 in USA
Share Price
$47.50
Change (1 day)
+1.78%
52-Week Range
$45.44 - $84.67
All Time High
$89.09
About

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various… Read more